2-甲基-5-硝基苯并三唑 | 36793-96-1

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并三唑类
• 中文名称: 2-甲基-5-硝基苯并三唑
• 英文名称: 2-methyl-5-nitro-2H-benzotriazole
• 英文别名: 2-methyl-5-nitro-2H-benzo[d][1,2,3]triazole；2-methyl-5-nitrobenzotriazole；2-methyl-5-nitro-benzotriazolium betaine；2-methyl-5-nitro-2H-benzotriazole；2-Methyl-5-nitro-2H-benzotriazol；2-Methyl-5-nitro-benzotriazol
• CAS: 36793-96-1
• 化学式: C₇H₆N₄O₂
• 分子量: 178.15
• InChiKey: FXBLOJHEYCJMRT-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.7
• 重原子数：
  13
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.14
• 拓扑面积：
  76.5
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  2-甲基-5-硝基苯并三唑 在 镍 氢气 作用下， 以 甲醇 为溶剂， 生成 2-methyl-2H-benzotriazol-5-amine
  参考文献：
  名称：

  Milata, Viktor; Ilavsky, Dusan; Goljer, Igor, Bulletin de la Societe Chimique de France, 1996, vol. 133, # 9, p. 897 - 902

  摘要：

  DOI：
• 作为产物：
  描述：

  2-甲基-2H-苯并三唑 在 水 、 硝酸 作用下， 生成 2-甲基-5-硝基苯并三唑
  参考文献：
  名称：

  Wiley; Hussung, Journal of the American Chemical Society, 1957, vol. 79, p. 4395,4399

  摘要：

  DOI：

文献信息

• Pyrazole compounds
  申请人：——

  公开号：US20030060453A1

  公开（公告）日：2003-03-27

  Pharmaceutical compositions and compounds are provided. The compounds of the invention demonstrate anti-proliferative activity, and may promote apoptosis in cells lacking normal regulation of cell cycle and death. In one embodiment of the invention, pharmaceutical compositions of the compounds in combination with a physiologically acceptable carrier are provided. The pharmaceutical compositions are useful in the treatment of hyperproliferative disorders, which disorders include tumor growth, lymphoproliferative diseases, angiogenesis. The compounds of the invention are substituted pyrazoles and pyrazolines.

  提供药物组合物和化合物。发明的化合物显示出抗增殖活性，并且可能促进缺乏正常细胞周期和死亡调控的细胞的凋亡。发明的一个实施例提供了化合物与生理可接受载体组合的药物组合物。该药物组合物可用于治疗过度增殖障碍，包括肿瘤生长、淋巴增殖性疾病、血管生成。发明的化合物是取代吡唑和吡唑啉。
• Azoles. Part 43: Reactions of N-(Phenylsulphonylmethyl)- and N-(Phenylsulphinylmethyl)azoles with some Nitroarenes
  作者：Marek K Bernard

  DOI：10.1016/s0040-4020(00)00624-4

  日期：2000.9

  cleavage of the phenylsulphonyl group, whereas the t-BuOK/DMF system at low temperature promotes to a greater extent oxidation of the σ-adducts. When 1-(phenylsulphinylmethyl)azoles were used for the reaction only elimination of the phenylsulphinyl group was observed.

  在室温下，在KOH / DMSO系统中用1-（苯磺酰基甲基）唑对硝基芳烃进行处理通常会导致苯磺酰基的裂解，而在低温下的t- BuOK / DMF系统则会在更大程度上促进σ-的氧化。加合物。当将1-（苯基亚磺酰基甲基）唑用于反应时，仅观察到苯基亚磺酰基的消除。
• Immugenic compositions and diagnostic and therapeutic uses thereof
  申请人：Zhang Zaihui

  公开号：US20050272709A1

  公开（公告）日：2005-12-08

  Pharmaceutical compositions and compounds are provided. The compounds of the invention deomonstrate anti-proliferative activity, and may promote apoptosis in cells lacking normal regulation of cell cycle and death. In one embodiment of the invention, pharmaceutical compositions of the compounds in combination with a physiologically acceptable carrier are provided. The pharmaceutical compositions are useful in the treatment of hyperproliferative disorders, which disorders include tumor growth, lymphoproliferative diseases, angiogenesis. The compounds of the invention are substituted pyrazoles and pyrazolines.

  本发明提供了制药组合物和化合物。本发明的化合物表现出抗增殖活性，并可能促进缺乏正常细胞周期和死亡调节的细胞凋亡。在本发明的一种实施例中，提供了化合物与生理可接受载体的制药组合物。这些制药组合物可用于治疗高增殖性疾病，包括肿瘤生长、淋巴增殖性疾病、血管生成等疾病。本发明的化合物是取代的吡唑和吡唑啉。
• Hydrazonopyrazole derivatives and their use as therapeutics
  申请人：Valocor Therapeutics, Inc.

  公开号：US07875728B2

  公开（公告）日：2011-01-25

  Pharmaceutical compositions and compounds are provided. The compounds of the invention demonstrate anti-proliferative activity, and may promote apoptosis in cells lacking normal regulation of cell cycle and death. In one embodiment of the invention, pharmaceutical compositions of the compounds in combination with a physiologically acceptable carrier are provided. The pharmaceutical compositions are useful in the treatment of hyperproliferative disorders, which disorders include tumor growth, lymphoproliferative diseases, angiogenesis. The compounds of the invention are substituted pyrazoles and pyrazolines.

  本发明提供了药物组合物和化合物。本发明的化合物表现出抗增殖活性，并可能促进缺乏正常细胞周期和死亡调节的细胞凋亡。在本发明的一种实施例中，提供了化合物与生理上可接受的载体组合的药物组合物。这些药物组合物在治疗增生性疾病方面是有用的，这些疾病包括肿瘤生长，淋巴增生性疾病和血管生成。本发明的化合物是取代的吡唑和吡唑烷。
• HYDRAZONOPYRAZOLE DERIVATIVES AND THEIR USE AS THERAPEUTICS
  申请人：Zhang Zaihui

  公开号：US20110237783A1

  公开（公告）日：2011-09-29

  Pharmaceutical compositions and compounds are provided. The compounds of the invention demonstrate anti-proliferative activity, and may promote apoptosis in cells lacking normal regulation of cell cycle and death. In one embodiment of the invention, pharmaceutical compositions of the compounds in combination with a physiologically acceptable carrier are provided. The pharmaceutical compositions are useful in the treatment of hyperproliferative disorders, which disorders include tumor growth, lymphoproliferative diseases, angiogenesis. The compounds of the invention are substituted pyrazoles and pyrazolines.

  本发明提供了药物组合物和化合物。本发明的化合物表现出抗增殖活性，并可能促进缺乏正常细胞周期和死亡调节的细胞凋亡。在本发明的一个实施例中，提供了与生理学上可接受的载体结合的化合物的药物组合物。这些药物组合物在治疗增生性疾病方面有用，这些疾病包括肿瘤生长、淋巴增生性疾病和血管生成等疾病。本发明的化合物是取代的吡唑和吡唑啉。